Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech , COVID-19 vaccine for use and said ...

As the race to develop oncology bispecifics heats up, Pfizer has offered a first look at its strategy to dethrone Keytruda and establish its ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

Sunday 9 November 2025 marks the fifth anniversary of a defining moment in stock market history. Pfizer/BioNTech’s ...

Fintel reports that on November 10, 2025, HC Wainwright & Co. maintained coverage of BioNTech SE - Depositary Receipt ...

In a press release on Friday, Metsera said Pfizer had made an improved offer to acquire it for up to $86.25 per share, in a deal worth around $10 billion. Metsera said its board “unanimously ...

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...

The nucleic acid therapeutics market is growing due to rising genetic and chronic disease prevalence, expanding genomics R&D, ...

The largest study of its kind has revealed that the Pfizer-BioNTech Covid-19 vaccine presents considerably fewer problems for ...

The risk of rare heart, vascular, or inflammatory complications in children is higher after Covid-19 infection than after ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

For children, the safer path during the pandemic wasn’t a roll of the dice with infection - it was vaccination.